Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-05-28
1994-04-19
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540542, 540555, A61K 3155, C07D49522
Patent
active
053045530
ABSTRACT:
A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases, ##STR1## in which R.sup.1 and R.sup.2 are hydrogen or an alkyl, R.sup.3 is hydrogen or a halogen, R.sup.4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.
REFERENCES:
patent: 4959361 (1990-09-01), Walser
patent: 4960770 (1990-10-01), Moriwaki et al.
patent: 4968794 (1990-11-01), Weber et al.
patent: 5049559 (1991-09-01), Braguet et al.
patent: 5049560 (1991-09-01), Esanu et al.
Tsunoda et al, Chemical Abstract vol. 114, No. 55582u (1990).
Abe Shinya
Asano Osamu
Clark Richar S. J.
Harada Koukichi
Katayama Kouichi
Datlow Philip I.
Eisai Co. Ltd.
Shah Mukund J.
LandOfFree
1,4-diazepine derivative and its pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,4-diazepine derivative and its pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-diazepine derivative and its pharmaceutical use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-19873